BIOMOOD

Antiepileptic

Topiramate

Composition

Each coated tablet contains: 
Topiramate 25, 50 or 100 mg
Excipients q.s.

Presentations

BIOMOOD® 25 mg: 30 coated tablets pack  
BIOMOOD® 50 mg: 30 coated tablets pack 
BIOMOOD® 100 mg: 30 coated tablets pack 

Indications

BIOMOOD® is indicated in: 

• Epilepsy
- Indicated as initial monotherapy in patients 6 years of age and older with partial onset or primary generalized tonic-clonic seizures
- Indicated as an add-on therapy in epileptic adult patient and children between 2 and 16 years having focal seizures or focal onset which then generalize
- Indicated in adults and children over 2 years as an add-on therapy of crisis associated with Lennox-Gastaut syndrome

• Migraine
- Indicated in adult patients for prophylaxis of migraine

The acute treatment of migraine has not been studied